FANGDA PARTNERS http://www.fangdalaw.com 中国上海市石门一路 288 号 电子邮件 E-mail: email@fangdalaw.com 兴业太古汇香港兴业中心二座 24 楼 电 话 Tel.: +86-21- 2208 1166 邮政编码：200041 传 真 Fax.: +86-21-5298 5599 HKRI Taikoo Hui Shanghai, PRC 上海市方达律师事务所 关于控股股东增持上海奥浦迈生物科技股份有限公司股份的 法律意见书 致：上海奥浦迈生物科技股份有限公司 上海市方达律师事务所（以下简称"本所"）是具有中华人民共和国境内法 律执业资格的律师事务所。本所受上海奥浦迈生物科技股份有限公司（以下简称 "奥浦迈"或"公司"）的委托，就奥浦迈控股股东肖志华先生（以下简称"增 持人"）自2024年1月31日至2025年5月31日期间内（以下简称"本次增持期间"） 通过上海证券交易所交易系统以集中竞价交易方式增持奥浦迈股份（以下简称 "本次增持" ）符合免于发出要约的情形等有关事宜出具本法律意见书。 本法律意见书依据《中华人民共和国证券法》（以下简称 ...

Core Viewpoint - The company Shanghai Tunnel Engineering Co., Ltd. (隧道股份) announced that its controlling shareholder, Shanghai Urban Construction (Group) Co., Ltd., will increase its stake in the company by purchasing 21.8283 million A-shares, representing 0.6943% of the total share capital, for a total investment of RMB 132 million [1] Summary by Categories Shareholding Increase - The controlling shareholder plans to conduct the share purchase from May 16 to May 22, 2025, through centralized bidding on the Shanghai Stock Exchange [1] - The total number of shares to be acquired is 21.8283 million, which constitutes 0.6943% of the company's total share capital [1] Funding Sources - The funds for this share purchase will come from the controlling shareholder's own funds and self-raised funds [1] - The self-raised funds include a loan of up to RMB 450 million from Industrial and Commercial Bank of China [1]

Core Viewpoint - The announcement details the completion of the share buyback plan by the controlling shareholder of Hubei Three Gorges New Materials Co., Ltd., indicating confidence in the company's future development and long-term investment value [1][2]. Summary by Sections 1. Buyback Plan Overview - The controlling shareholder, Dangyang Urban Investment Co., Ltd., planned to increase its stake in the company by purchasing shares worth between 0.7 billion and 1 billion yuan starting from November 23, 2024, over a period of six months [1][2]. - The buyback was executed through the Shanghai Stock Exchange's trading system via centralized bidding [2]. 2. Implementation Results - From December 2 to December 4, 2024, the controlling shareholder acquired 11,601,500 shares, raising its total holdings to 247,612,293 shares, which is 21.34% of the total share capital [3][4]. - Between January 6 and January 15, 2025, an additional 11,647,100 shares were purchased, increasing total holdings to 259,259,393 shares, representing 22.01% of the total share capital [4]. - On April 9 and 10, 2025, the shareholder bought another 4,530,500 shares, bringing total holdings to 263,789,893 shares, which is 22.99% of the total share capital [4]. 3. Shareholding Changes - Prior to the buyback, the controlling shareholder held 236,010,793 shares (20.34% of total capital), and its concerted party held 65,581,208 shares [2]. - After the completion of the buyback, the total shares held by the controlling shareholder and its concerted party increased from 301,592,001 shares (25.99%) to 329,371,101 shares (28.39%) [4][5]. 4. Compliance and Future Actions - The buyback plan complies with relevant laws and regulations, and the controlling shareholder has committed not to reduce its holdings within the statutory period following the completion of the buyback [5].

Group 1 - The controlling shareholder, Sichuan Jinjue, plans to increase its stake in Hongli Zhihui (300219) by investing between 25 million and 50 million yuan within six months from the announcement date [1] - The increase in shares will be executed through the Shenzhen Stock Exchange via centralized bidding or block trading [1] - Prior to the planned increase, Sichuan Jinjue holds 213 million shares, accounting for 30.08% of the total share capital of the company [1]

Core Viewpoint - The controlling shareholder of Shanghai Laishi Blood Products Co., Ltd., Haiyingkang (Qingdao) Medical Technology Co., Ltd., plans to increase its shareholding in the company to enhance investor confidence and demonstrate long-term investment value [3][6]. Group 1: Shareholding Details - Haiyingkang currently holds 1,474,578,052 shares, accounting for 22.21% of the total share capital of Shanghai Laishi [3][4]. - Including the voting rights of 437,069,656 shares held by Grifols, S.A., Haiyingkang controls a total of 1,911,647,708 shares, representing 28.80% of the total share capital [3][4]. Group 2: Increase Plan Details - The planned increase in shareholding amounts to no less than RMB 250 million and no more than RMB 500 million, excluding transaction costs [6][7]. - The increase will be executed through centralized bidding without a specified price range, based on the reasonable judgment of the stock's value [6][8]. - The implementation period for this plan is within six months from the announcement date, with provisions for delays if the stock is suspended [7][9]. Group 3: Funding and Commitment - The funding for the share purchase will come from self-owned funds and a special loan, with the loan portion not exceeding 90% of the total [7][9]. - A loan commitment of up to RMB 450 million has been issued by Bank of China to support this share purchase [7][9]. - Haiyingkang commits to completing the share increase within the specified period and will not reduce its holdings during this time [9].

Core Viewpoint - Rongsheng Petrochemical (002493) announced that its controlling shareholder, Rongsheng Holdings, will increase its stake in the company by acquiring 204 million shares, representing 2.01% of the total share capital, from January 22, 2024, to May 21, 2025 [1] Summary by Relevant Categories Shareholding Increase - Rongsheng Holdings will conduct the share purchase through the Shenzhen Stock Exchange via centralized bidding [1] - The funds for the share acquisition will come from self-owned funds and bank loans [1] Ownership Structure - After the share increase, Rongsheng Holdings and its concerted parties will hold a total of 6.057 billion shares, accounting for 59.8198% of the total share capital [1] Compliance - The share increase complies with relevant laws and regulations, including the Securities Law and the Measures for the Administration of the Acquisition of Listed Companies [1]

安孚科技（603031）公告，控股股东前海荣耀在第二笔增持专项贷款1000万元到位后，立即实施增持。 本次增持共26.17万股，增持总金额699.93万元，占公司总股本的0.12%。截至目前，累计已增持股份金 额4588.44万元，累计已增持股份数量162.56万股，占公司总股本的0.77%。控股股东将继续择机实施增 持计划，并计划在2025年10月10日前完成。 ...

天康生物 证券代码：002100 证券简称：天康生物 公告编号：2025-033 天康生物股份有限公司 关于控股股东增持公司股份计划实施完成 公司控股股东新疆生产建设兵团国有资产经营有限责任公司保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： ? 增持计划：天康生物股份有限公司（以下简称"公司"）控股股东新疆生 产建设兵团国有资产经营有限责任公司（以下简称"兵团国资公司"）计划自 2024 年 11 月 20 日起 6 个月内增持本公司股份，计划增持金额不少于人民币 10,000 万 元，不超过人民币 20,000 万元，本次增持不设定价格区间。 ? 增持进展：截至 2025 年 5 月 19 日暨本次增持计划实施期限届满，兵团国 资公司通过深圳证券交易所交易系统以集中竞价方式增持公司股份 24,321,903 股，占公司总股本的 1.78%，增持金额为 159,890,689.93 元，达到增持计划下限 金额，且未超上限，本次增持计划实施完毕。本次增持后，兵团国资公司持有公 司股份 318,90 ...

盈趣科技（002925）公告，公司控股股东万利达工业计划自2024年11月16日起6个月内，通过深圳证券 交易所集中竞价交易方式增持公司股份，增持总金额不低于1亿元，不超过2亿元。截至公告披露日，万 利达工业累计增持公司股份641.26万股，占公司总股本的0.82%，增持金额为1亿元(不含交易费用)。增 持后，万利达工业及其一致行动人持股比例由54.33%增至55.16%。 ...

冀中能源（000937）公告，控股股东冀中能源集团于2024年11月29日至2025年5月14日期间，通过深圳 证券交易所交易系统以集中竞价方式累计增持公司股票3118.31万股，占公司总股本的0.88%。本次权益 变动后，冀中能源集团及其一致行动人持有公司股份的比例由57.16%增加至58.04%。 ...